Clinical Trial: A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Assessment of the Calcimimetic Agent AMG 073 for the Treatment of Subjects With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism.

Brief Summary: This study will assess an investigational medication for patients with severe primary hyperparathyroidism or parathyroid cancer.

Detailed Summary:
Sponsor: Amgen

Current Primary Outcome: Changes in serum calcium and PTH

Original Primary Outcome:

Current Secondary Outcome: Safety and tolerability of cinacalcet

Original Secondary Outcome:

Information By: Amgen

Dates:
Date Received: May 17, 2002
Date Started: April 2001
Date Completion:
Last Updated: May 6, 2013
Last Verified: May 2013